Tagged with ALK

Serbia Goran Djuric, the founder of EuroCons Group, shares an overview of the rationale and business scope of the company’s activities while underlining the importance of bringing innovative solutions to the market. Further, he discusses the particular initiatives the company is involved in, as well as sharing his advice for entrepreneurs…

Serbia Milos Davidovic, Mylan’s country manager responsible for Serbia, Slovenia, Macedonia, and Montenegro, reveals the made-to-measure market approach that he has been implementing in the region for the past six years while highlighting the crucial role of employing a highly educated, expert workforce. What potential did Mylan see in Serbia, and…

Serbia Predrag Lukic, general manager of Amicus, a new and exciting bridging service for MNCs looking to expand into Serbia and the Balkans, reveals the keys to accessing the region and how best to take advantage of the professional talent pool in Serbia. Through careful study of the market and by…

Serbia Milica Glisic, with over 15 years of experience in the pharma business and ten years at Wörwag Pharma, discusses the strong workforce in the Balkans, Wörwag Pharma’s mission in the West Balkan region, and the company’s dedication to providing unique and efficient solutions for diabetes and concomitant complications. Could you…

Switzerland Recently arrived from Germany, ALK’s new general manager for Switzerland highlights some of the unique features of the Swiss allergology field, and some of the opportunities for ALK to positively impact patients’ lives in the future.   ALK says roughly one in five people suffer from some degree of allergy…

Pharma Sean Connor, General Manager Benelux and UK/ROI for ALK, details the company’s strategy both in terms of products and therapeutic areas and provides us with his assessment of Netherlands regulatory environment and market access. We are becoming, both at national and global levels, a company that supplies highly evidence-based medicines,…

pharma The President of Pfizer France reveals how the biggest challenge the French pharma industry faces is to gain credit for its contribution to improve people´s quality of life; why France is and will always be important for any large pharma company, despite some particular challenges; and how France´s unique strength…

Pharma ALK’s Denis Delval reveals how France is number one in terms of volumes for the group and number two in terms of revenues, just behind Germany; how the four Danes – Novo Nordisk, Leo, Lundbeck and ALK – are good examples of the best pupils in class when it comes…

pharma Rikus Wolbers, Director at Novio Tech Campus, a key international incubator for R&D and manufacturing companies who are active at the interface of life sciences and high tech, and John Schalken, Program Director SMB Life Sciences, give an overview of the impressive developments in the Nijmegen area and the potential…

R&D Graham Skarnvad arrived to Spain as country manager of ALK’s Spanish affiliate at the end of 2009, right when the crisis was in full swing. Later on he took the full legal responsibility – also as: General Manager for Spain, and Portugal. He discusses his mandate and increased in investment…

CEO Talk In the second part of this two-part interview, the chairman of TTY looks back at his experiences in the Taiwanese market, and assess what could have been done differently with his company. He also offers advice to the next generation of Taiwanese pharmaceutical companies. To read the first part of…